Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Lexaria Bioscience Corp.
LEXX · SEC Filings
website
7
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprieta...
Price
4.54
Market Cap
9.56 M
Float
2.06 M
Country
CA
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about LEXX
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Lexaria Bioscience Corp.
LEXX · SEC Filings
2.06 M
Float
4.54
Price
9.56 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 13, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 13, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 13, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 26, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 14, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Lexaria Bioscience Announces Warrant Exercise Transaction for Approximately $5.9 Million in Gross Proceeds
Sep 9, 2026
8-K
Lexaria Bioscience Corp. Receives AUD$3.67 Million Australian R&D Tax Incentive Credit
Sep 1, 2026
8-K
Lexaria Bioscience Corp. Regains Compliance with Nasdaq Bid Price Requirement
Aug 17, 2026
8-K
Lexaria Bioscience Corp. Receives Nasdaq Delisting Notification and Files for Hearing
Aug 10, 2026
8-K
Lexaria Bioscience Corp. Announces 1-for-15 Reverse Stock Split
Jul 30, 2026
8-K
Lexaria Bioscience Corp. Receives Nasdaq Bid Price Deficiency Notice
Feb 6, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]
Oct 13, 2026
424B3
SHARE RESALE REGISTRATION | Shares: 2,754,756
Jan 14, 2026
424B5
REGISTERED OFFERING
Dec 16, 2025
424B3
UPDATED | SHARE RESALE REGISTRATION | Shares amount: 2,760,000 | Warrants amount: 2,666,667
Dec 9, 2025
424B5
REGISTERED OFFERING
Sep 29, 2025
424B5
REGISTERED OFFERING
Apr 25, 2025
Registrations
TYPE
HEADLINE
FILED AT
S-3
SHARE RESALE REGISTRATION EFFECTIVE, DATED 2026-10-13
Oct 1, 2026
D
Form D - Notice of Exempt Offering of Securities - Item 06b
Sep 18, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 28, 2026
S-1
SHARE RESALE REGISTRATION
Dec 29, 2025
D
Form D - Notice of Exempt Offering of Securities - Item 06b
Dec 18, 2025
POS AM
Form POS AM - Post-Effective amendments for registration statement
Dec 5, 2025
Proxies
TYPE
HEADLINE
FILED AT
DEF 14A
Form DEF 14A - Other definitive proxy statements
Dec 10, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Nov 27, 2024
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Nov 12, 2024
DEF 14A
Form DEF 14A - Other definitive proxy statements
Mar 6, 2024
DEF 14A
Form DEF 14A - Other definitive proxy statements
Aug 23, 2023
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Aug 9, 2023
Ownerships
TYPE
HEADLINE
FILED AT
S-3
Form S-3 - Registration statement under Securities Act of 1933
Oct 1, 2026
4
BUNKA CHRISTOPHER (Reporting)
Mar 18, 2026
4
BUNKA CHRISTOPHER (Reporting)
Jul 30, 2025
4
McKechnie William Edward (Reporting)
Jul 30, 2025
4
DOCHERTY JOHN MARTIN (Reporting)
Jul 30, 2025
4
Carle Vanessa (Reporting)
Jul 30, 2025
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Oct 14, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Jan 15, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Dec 10, 2025
EFFECT
Form EFFECT - Notice of Effectiveness
Dec 9, 2025
CORRESP
Form CORRESP - Correspondence
Dec 5, 2025
EFFECT
Form EFFECT - Notice of Effectiveness
Jan 31, 2025
